A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is 639,45 zł, with a 24-hour trading volume of 1,17B zł. The asset's market cap is 991,71B zł, after moving -0.23% in the last day.
Tokenized AstraZeneca PLC is trading at 362,09 zł, with a tokenized market cap of 205,01M zł and a 24-hour trading volume of 2,79M zł. The tokenized asset has moved 14.66% in the past 24 hours.